30 November - 15:00 -16:00 GMT / 16:00 – 17:00 CET
Theranostics is the term used to describe the
combination of using one radioactive drug to identify (diagnose) and a second
radioactive drug to deliver therapy to treat the main tumor and any metastatic
tumors. Join this upcoming webinar where Billev East will delve into the 'Concept of Theranostics', exploring the specific requirements and challenges encountered during registration procedures for radiopharmaceutical diagnostic and therapeutic agents. Additionally, Billev East will address orphan designation procedures for radiopharmaceuticals, discussing best practices and outstanding issues.
Target Audience: Regulatory specialists
Learning Objectives:
o Concept of theranostics
o Specific requirements and challenges encountered during registration procedures for radiopharmaceutical diagnostic and therapeutic agents
o Orphan designation procedures for radiopharmaceuticals – best practices and outstanding issues
Presenters:
o Jana Brajdih Cendak, MD, Medical and Pharmacovigilance Lead
o Suzana Šalinger, Regulatory Affairs Manager

Disclaimer: Whilst TOPRA is running this webinar for Billev East, this is not an endorsement of Billev East, Billev East's affiliates, employees or its products and services. TOPRA is also not responsible for the content or views expressed during the webinar.
How do I register?
Simply log in or create an account and register below.
Pricing
- Members: free
- Non-members: free
Terms and Conditions
By purchasing this webinar, you are agreeing to TOPRA's training terms and conditions.